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Gradual Increases in Scheduled and Actual Early Follow Up after 
Heart Failure Hospitalization: Two Steps Forward or One Step 
Forward?
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1Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard 
Medical School
2Section of Advanced Heart Failure, University of Colorado School of Medicine
Since roll out of the Hospital Readmission Reduction Program (HRRP) in 2012, which 
penalizes hospitals up to 3% of their total Medicare payments if 30-day readmission rates 
for selected chronic conditions are in excess of the national average, heart failure (HF) 
readmission reduction has been center stage for hospital administrators, clinicians, and 
health-policy researchers.1 Although the goal of improving care around the time of 
hospitalization is laudable, specific actions for reducing excess HF readmissions are not 
offered by the HRRP. Furthermore, the majority of high-quality randomized trials of varied 
HF transitional care interventions have failed to reduce readmission rates. Instead, hospitals 
have needed to rely on locally implemented solutions often employing care processes with 
face validity.2
A logical and commonly championed HF transitional care intervention is early ambulatory 
care follow up following hospital discharge. In 2009 Hernandez and colleagues reported an 
association between hospital-level early follow-up and decreased rates of 30-day 
readmissions.3 Despite limitations of this retrospective observational study design and 
significant potential for residual confounding, these results were widely cited, reported in 
the lay press, and disseminated at scientific meetings. Early ambulatory follow-up after a HF 
hospital discharge was rapidly incorporated into hospital quality improvement policies, 
transitional care initiatives, and professional society guidelines.2, 4
In this issue of Circulation: Heart Failure, DeVore and colleagues examine temporal trends 
in scheduled early follow up (defined as follow-up with any provider within 7 days of 
discharge) over the 3 years since the original Hernandez et al paper was published.5 Using 
the American Heart Association’s (AHA) Get With The Guidelines – Heart Failure 
(GWTG-HF) registry, they examined rates of early follow-up from 2009–2012. Scheduled 
follow up at the time of hospital discharge increased from 51 to 65%, and patients at higher 
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risk for post-discharge adverse events—those older, anemic, diabetic, or on warfarin—were 
more likely to be scheduled for early physician follow-up. In the subgroup analysis of 
Medicare fee-for-service beneficiaries who were linked to Medicare part B claims, of whom 
59.2% were scheduled for early physician follow up, actual early physician follow-up went 
from 26.7% to 30.4%. There are a number of both encouraging and troubling issues raised 
by these findings.
DeVore et al demonstrate that high-quality, observational research can leverage large data 
sets to influence clinical practice. Now incorporated into clinical guidelines, individual 
hospital policies, transitional care models, and even transitional care management payments, 
scheduling early follow-up (although not necessarily as stringent as the 7-day cut-off) has 
become a standard of care. A 14% absolute increase in scheduling for ambulatory follow up 
when applied to the approximately 1 million U.S. HF hospitalizations annually represents a 
major change in clinical practice.
Furthermore, predictors of patients with scheduled early follow-up include demographics 
and comorbidities associated with higher risk, such as older age, diabetes, chronic kidney 
disease, and anticoagulant use. Despite the frequent tendency in medicine to observe a risk-
treatment paradox, encouragingly in the case of follow up providers appear to be matching 
follow up scheduling to perceived risk.
However, these findings also demonstrate how implementation of care delivery 
interventions typically requires executing multiple steps to achieve the intended goal. While 
documented scheduling of appointments went up (the measure upon which hospitals are 
benchmarked in GWTG), the rate of actual early physician follow-up among this cohort was 
much lower. The rate of actual follow up was also lower than reported in the original 
Hernandez et al manuscript, where the median rate of hospital-level actual early follow-up 
from 2003–2006 was 38.3%.
The reasons for the gap between scheduled and actual follow up are not explained by the 
study, but anyone who has spent significant time arranging and providing clinic follow up 
can guess at some of the barriers. As this study points out predictors of patients with 
scheduled early follow-up include demographics and comorbidities associated with higher 
risk. Yet these may be the same patients with significant barriers to keeping outpatient 
appointments, especially early after discharge from a HF hospitalization as they may be 
weakened, homebound or lack the financial or caregiver support to get them to 
appointments. Hence this gap between scheduled and actual follow-up suggests the need for 
a better understanding of patient’s resources, support, and home environment to identify 
barriers to outpatient provider appointments. Solutions may include appointment reminders, 
removing impediments such as copays and lack of transportation. Alternatively other 
follow-up methods such as phone calls or home visits, and benchmarking hospitals on actual 
(rather than scheduled) follow up may be preferable to simply scheduling early provider 
follow-up appointments at the time of discharge. If the goal is to have patients seen in early 
follow up, the data provided here suggest it is going to take more than writing an 
appointment on the discharge paperwork to get patients into the clinic within 7 days.
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As we continue to work to make early follow up a reality, the lingering question is whether 
early discharge follow up, and in what form, actually improves outcomes for patients with 
HF. Intuitively it makes sense that patients with HF—at high risk for post-discharge 
morbidity and mortality by virtue of illness severity, comorbidities, and complex medicine 
regimens—would benefit from a clinic visit during the vulnerable period directly after 
discharge. However, increased contact with the medical system does not necessarily 
translate to less hospitalization. Recent telemonitoring trials have been resoundingly 
negative.6–8 The DOT-HF study showed that thoracic impedance alerts markedly increased 
hospitalization.9 Clinic visits could help catch errors in management … or they could lead 
people to send patients to the emergency department who may otherwise have gotten by at 
home.
When one critically reviews the evidence for early follow-up, major questions remain. The 
Hernandez et al findings demonstrated a hospital-level association between early follow-up 
and reduced 30-day readmission rates among hospitals in the 3 higher quartiles of early 
follow-up versus the lowest quartile of early follow up. However, among hospitals in the 
three higher quartiles of early follow-up there was no significant difference in readmission 
rates. If early physician follow up was a key variable in reducing readmission rates, one 
would expect a dose-related step-wise reduction in the odds of readmission moving from 
lowest to high quartiles hospitals-level early follow-up. This raises the obvious question 
given the study’s retrospective design of whether hospitals-level low rates of early physician 
follow-up is truly a causal variable associated with increased readmissions or rather a 
marker of other confounding variables or lack of a robust transitional care process. Indeed, 
another study looking at the relationship between early follow-up and readmission rates 
have not found such an association.10 Perhaps one of the explanations as to why less than a 
third of Medicare beneficiaries receive 7-day follow up is that healthcare providers lack 
reasonable assurance that such efforts will have the intended effect. Ambulatory follow up, 
like readmission, is resource intensive. If hospital systems are going to invest the resources 
needed to actually get these patients to the clinic within a week of discharge, then we should 
have further prospective evidence that this intervention truly improves the targeted outcome 
of reducing 30-day readmissions.
Perhaps most disturbing is that with all of the resources going into early follow up, there are 
no ongoing large randomized trials to ascertain its true effectiveness. While the efforts of the 
GWTG investigators help us understand the landscape of HF transitional care and 
ambulatory follow up with insights into what drives current care patterns, its ability to tell us 
what we should be doing is limited. These efforts must be combined with randomized 
interventional trials of care delivery. Pragmatic clinical trials across health systems are 
technically feasible, but to date have been limited. That culture must change if the U.S. is to 
make significant strides on reducing HF readmission, specifically, and getting more value 
for its health care dollar, generally.
The authors of the present study convincingly demonstrate the ability of well-designed 
observational research to change clinical practice. This is particularly important in an era of 
decreased federal funding for randomized clinical trials and increased focus on patient 
centered outcomes. Yet, their findings also demonstrate the challenges of translating desired 
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interventions into clinical practice and the need to identify barriers and facilitators of 
transitional care delivery. As for most clinical questions, observational data will never 
provide a clear answer to what works best. It has been said, “Until you spread your wings, 
you’ll have no idea how far you can walk.” Since 2009 we have made important but 
incremental progress on transitional care and readmissions for heart failure. It seems 
unlikely that we will take flight until we commit to a series of high-quality randomized data 
that elucidate causal relationships between various transitional care interventions and 
patient-centered outcomes.
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